Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Burning Rock Biotech Ltd ADR
(NQ:
BNR
)
6.320
+0.050 (+0.80%)
Streaming Delayed Price
Updated: 1:40 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Burning Rock Biotech Ltd ADR
< Previous
1
2
3
Next >
Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
June 01, 2024
Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in...
Via
Talk Markets
BNR Stock Earnings: Burning Rock Biotech Reported Results for Q1 2024
May 29, 2024
Burning Rock Biotech just reported results for the first quarter of 2024.
Via
InvestorPlace
Three AI Stocks That Are Trading At A Discount In April 2024
April 03, 2024
These AI stocks cover voice, logistics, and videos, and all of them are trading at a decent discount to their real value.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BNR Stock Earnings: Burning Rock Biotech Reported Results for Q4 2023
March 28, 2024
Burning Rock Biotech just reported results for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
March 11, 2024
Via
Benzinga
Earnings Preview: Burning Rock Biotech
March 27, 2023
Via
Benzinga
Recap: Burning Rock Biotech Q2 Earnings
August 31, 2022
Burning Rock Biotech (NASDAQ:BNR) reported its Q2 earnings results on Wednesday, August 31, 2022 at 05:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via
Benzinga
Earnings Scheduled For November 30, 2023
November 30, 2023
Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its third quarter. • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.45 per share on...
Via
Benzinga
Earnings Scheduled For May 30, 2023
May 30, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its first quarter.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 16, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 16, 2022
Pre-market stock movers are a hot topic among traders this morning as we cover all of the biggest news moving shares on Wednesday!
Via
InvestorPlace
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
November 15, 2022
Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.
Via
Benzinga
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
September 12, 2022
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
Via
Benzinga
Livent, Amgen And Some Other Big Stocks Moving Lower On Monday
September 12, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 31, 2022
Via
Benzinga
Dow Drops 100 Points; US Crude Oil Inventories Decline Higher-Than-Expected Last Week
August 31, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 100 points on Wednesday
Via
Benzinga
Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday
September 01, 2022
Gainers
Via
Benzinga
Earnings Scheduled For August 31, 2022
August 31, 2022
Companies Reporting Before The Bell • Hywin Holdings (NASDAQ:HYW) is expected to report earnings for its fourth quarter.
Via
Benzinga
Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
August 31, 2022
Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in...
Via
Benzinga
A Preview Of Burning Rock Biotech's Earnings
August 30, 2022
Burning Rock Biotech (NASDAQ:BNR) is set to give its latest quarterly earnings report on Wednesday, 2022-08-31. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 22, 2022
Via
Benzinga
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
August 23, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...
Via
Benzinga
Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session
August 22, 2022
Losers
Via
Benzinga
AMC Entertainment, Pharvaris And Some Other Big Stocks Moving Lower On Monday
August 22, 2022
Via
Benzinga
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
July 12, 2022
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 11, 2022
Via
Benzinga
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
July 11, 2022
Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.